Chemical Component Summary | |
---|---|
Name | Seladelpar |
Identifiers | 2-[4-[(2~{R})-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methyl-phenoxy]ethanoic acid |
Formula | C21 H23 F3 O5 S |
Molecular Weight | 444.465 |
Type | NON-POLYMER |
Isomeric SMILES | CCO[C@H](COc1ccc(cc1)C(F)(F)F)CSc2ccc(c(c2)C)OCC(=O)O |
InChI | InChI=1S/C21H23F3O5S/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26/h4-10,17H,3,11-13H2,1-2H3,(H,25,26)/t17-/m1/s1 |
InChIKey | JWHYSEDOYMYMNM-QGZVFWFLSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 53 |
Chiral Atom Count | 1 |
Bond Count | 54 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB12390 |
---|---|
Name | Seladelpar |
Groups | investigational |
Description | Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia. |
Synonyms |
|
Categories |
|
CAS number | 851528-79-5 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL230158 |
PubChem | 11236126 |
ChEMBL | CHEMBL230158 |